Liver Cirrhosis Completed Phase 3 Trials for Peginterferon alfa-2b (DB00022)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00048724Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)Treatment
NCT00039871PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)Treatment
NCT00687219Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)Treatment